7571 - 7580 of 8808 Results
Title
Year
-
OPENTitle: Comparative study of cerebrospinal fluid α‐synuclein seeding aggregation assays for diagnosis of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 4Start Page: 536End Page: 544Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27646Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27646Citation Count: 193
-
OPENTitle: Association of sulfonylureas with the risk of dementia: A population‐based cohort studyJournal Name: Journal of the American Geriatrics SocietyPublisher: WileyVol: 71Issue #: 10Start Page: 3059End Page: 3070Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/jgs.18397Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jgs.18397Citation Count: 27
-
RESTRICTEDTitle: Impact of Parkinson's disease risk loci on age at onsetJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 6Start Page: 847End Page: 850Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26237Citation Count: 53
-
OPENTitle: Care access and utilization among medicare beneficiaries living with Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00523-yBest OA location URL: https://www.nature.com/articles/s41531-023-00523-y.pdfCitation Count: 23
-
RESTRICTEDTitle: Evaluation of a Low-Toxicity PARP Inhibitor as a Neuroprotective Agent for Parkinson’s DiseaseJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 58Issue #: 8Start Page: 3641End Page: 3652Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12035-021-02371-4Citation Count: 14
-
RESTRICTEDTitle: α-synuclein overexpression and the microbiome shape the gut and brain metabolome in miceJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00816-wBest OA location URL: https://doi.org/10.1038/s41531-024-00816-wCitation Count: 3
-
OPENTitle: A blood-based DNA damage signature in patients with Parkinson’s disease is associated with disease progressionJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 5Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s43587-025-00926-xBest OA location URL: https://www.nature.com/articles/s43587-025-00926-x.pdfCitation Count: 0
-
OPENTitle: High-content phenotypic screen to identify small molecule enhancers of Parkin-dependent ubiquitination and mitophagyJournal Name: SLAS DiscoveryPublisher: Elsevier BVVol: 28Issue #: 3Start Page: 73End Page: 87Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.slasd.2022.12.004Best OA location URL: http://slas-discovery.org/article/S2472555222137160/pdfCitation Count: 11
- α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease2020OPENTitle: α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s diseaseJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-020-15626-wBest OA location URL: https://www.nature.com/articles/s41467-020-15626-w.pdfCitation Count: 341
-
OPENTitle: Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient miceJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 4Issue #: 13Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci.insight.126769Best OA location URL: https://doi.org/10.1172/jci.insight.126769Citation Count: 22